Prodrugs

Do They Have Advantages in Clinical Practice?

V. J. Stella, W. N.A. Charman, V. H. Naringrekar

Research output: Contribution to journalReview ArticleResearchpeer-review

159 Citations (Scopus)

Abstract

Prodrugs are pharmacologically inactive chemical derivatives of a drug molecule that require a transformation within the body in order to release the active drug. They are designed to overcome pharmaceutical and/or pharmacokinetically based problems associated with the parent drug molecule that would otherwise limit the clinical usefulness of the drug. The scientific rationale, based on clinical, pharmaceutical and chemical experience, for the design of various currently used prodrugs is presented in this review. The examples presented are by no means comprehensive, but are representative of the different ways in which the prodrug approach has been used to enhance the clinical efficacy of various drug molecules.

Original languageEnglish
Pages (from-to)455-473
Number of pages19
JournalDrugs
Volume29
Issue number5
DOIs
Publication statusPublished - 1 Jan 1985
Externally publishedYes

Cite this

Stella, V. J. ; Charman, W. N.A. ; Naringrekar, V. H. / Prodrugs : Do They Have Advantages in Clinical Practice?. In: Drugs. 1985 ; Vol. 29, No. 5. pp. 455-473.
@article{88f8f9feac4c40e984b902c8c141b0de,
title = "Prodrugs: Do They Have Advantages in Clinical Practice?",
abstract = "Prodrugs are pharmacologically inactive chemical derivatives of a drug molecule that require a transformation within the body in order to release the active drug. They are designed to overcome pharmaceutical and/or pharmacokinetically based problems associated with the parent drug molecule that would otherwise limit the clinical usefulness of the drug. The scientific rationale, based on clinical, pharmaceutical and chemical experience, for the design of various currently used prodrugs is presented in this review. The examples presented are by no means comprehensive, but are representative of the different ways in which the prodrug approach has been used to enhance the clinical efficacy of various drug molecules.",
author = "Stella, {V. J.} and Charman, {W. N.A.} and Naringrekar, {V. H.}",
year = "1985",
month = "1",
day = "1",
doi = "10.2165/00003495-198529050-00002",
language = "English",
volume = "29",
pages = "455--473",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "5",

}

Prodrugs : Do They Have Advantages in Clinical Practice? / Stella, V. J.; Charman, W. N.A.; Naringrekar, V. H.

In: Drugs, Vol. 29, No. 5, 01.01.1985, p. 455-473.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Prodrugs

T2 - Do They Have Advantages in Clinical Practice?

AU - Stella, V. J.

AU - Charman, W. N.A.

AU - Naringrekar, V. H.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Prodrugs are pharmacologically inactive chemical derivatives of a drug molecule that require a transformation within the body in order to release the active drug. They are designed to overcome pharmaceutical and/or pharmacokinetically based problems associated with the parent drug molecule that would otherwise limit the clinical usefulness of the drug. The scientific rationale, based on clinical, pharmaceutical and chemical experience, for the design of various currently used prodrugs is presented in this review. The examples presented are by no means comprehensive, but are representative of the different ways in which the prodrug approach has been used to enhance the clinical efficacy of various drug molecules.

AB - Prodrugs are pharmacologically inactive chemical derivatives of a drug molecule that require a transformation within the body in order to release the active drug. They are designed to overcome pharmaceutical and/or pharmacokinetically based problems associated with the parent drug molecule that would otherwise limit the clinical usefulness of the drug. The scientific rationale, based on clinical, pharmaceutical and chemical experience, for the design of various currently used prodrugs is presented in this review. The examples presented are by no means comprehensive, but are representative of the different ways in which the prodrug approach has been used to enhance the clinical efficacy of various drug molecules.

UR - http://www.scopus.com/inward/record.url?scp=0021800252&partnerID=8YFLogxK

U2 - 10.2165/00003495-198529050-00002

DO - 10.2165/00003495-198529050-00002

M3 - Review Article

VL - 29

SP - 455

EP - 473

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 5

ER -